Review of Safety Using Rilonacept in Preventing Gout Exacerbations (RE-SURGE)
This study has been completed.
Information provided by (Responsible Party):
First received: February 21, 2009
Last updated: December 1, 2011
Last verified: December 2011
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||January 2011|
|Primary Completion Date:||January 2011 (Final data collection date for primary outcome measure)|
|Certification or Request for Extension to Delay Results Received:||January 5, 2011|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Sundy JS, Schumacher HR, Kivitz A, Weinstein SP, Wu R, King-Davis S, Evans RR. Rilonacept for gout flare prevention in patients receiving uric acid-lowering therapy: results of RESURGE, a phase III, international safety study. J Rheumatol. 2014 Aug;41(8):1703-11. doi: 10.3899/jrheum.131226. Epub 2014 Jul 15.